Biotech Values

[jaybird249]

STXS:NASDAQ $1.28 7 MM float Medical robotics

Medical robotics is one of the hottest fields. HNSN and STXS historically traded at over $100 MM market caps.
After doing a reverse split STXS has been pouunded down to an insane $9 MM market cap even though it is posied to achieve positive cash flow and earnings in 2013 for the first time ever.

-Agressive cost cuts have reduced breakeven point.
-The company just confirmed business is accelerating. With the upturn in business and cost cuts, STXS should be cash flow positive by year end.
-Just completed debt financing with venture fund convertible at $3.30 per share.

-The potential upside here is significant.
If HNSN recently had a $100 MM market cap with tons of losses, what kind of value can STXS achieve with profitability?

STXS IS NOW IN ITS BEST SHAPE IN HISTORY, TRADING AT A PRE SPLIT PRICE OF 12 CENTS. These insane prices will soon be a thing of the past wnen tax loss selling ends.